Cresemba (isavuconazonium sulfate) — Blue Cross Blue Shield of New Mexico
other FDA labeled indication
Initial criteria
- Diagnosis of invasive aspergillosis OR invasive mucormycosis OR another FDA labeled or compendia supported indication
- Patient does NOT have any FDA labeled contraindications to the requested agent
Approval duration
6 months (Ohio Fully Insured/HIM Shop 12 months)